Results 171 to 180 of about 97,890 (300)

Patient‐Reported Outcomes of Palatopharyngeal Surgery Without Tonsillectomy: A Meta‐Analysis

open access: yesThe Laryngoscope, EarlyView.
Palatopharyngeal surgery without tonsillectomy leads to clinically meaningful improvements in daytime sleepiness and snoring, but patient‐reported outcomes vary markedly by surgical technique. Suture‐based procedures, muscle relocation, cold‐steel approaches, and powered instruments show the largest and durable benefits, with no evidence of effect ...
Samuel Tschopp   +4 more
wiley   +1 more source

Identifying High‐Risk Children Safe for Same‐Day Discharge After Tonsillectomy

open access: yesThe Laryngoscope, EarlyView.
ABSTRACT Objective Current guidelines recommend overnight admission for children with severe obstructive sleep apnea (OSA) and obesity undergoing tonsillectomy, although most have uneventful postoperative courses. We aimed to identify low‐risk subgroups within this high‐risk population who may be candidates for same‐day discharge. Methods Retrospective
Amy Ho   +9 more
wiley   +1 more source

Retention, blinding, and health outcomes from a rural pediatric obesity feasibility randomized control trial. [PDF]

open access: yesJ Pediatr Psychol
Lancaster BD   +14 more
europepmc   +1 more source

Utility of Preoperative Cardiac Workup for Children With Very Severe Obstructive Sleep Apnea

open access: yesThe Laryngoscope, EarlyView.
In this retrospective study, we aimed to examine the prevalence and utility of obtaining a preoperative cardiac workup in children with very severe obstructive sleep apnea (OSA) prior to adenotonsillectomy. Of 144 patients with very severe OSA, 38 patients (26.4%) underwent a preoperative cardiac workup, and three of those 38 had abnormal findings ...
Danny A. Elias   +3 more
wiley   +1 more source

The Gut Microbiota: An Essential Component in Understanding Pediatric Obesity: A Narrative Review. [PDF]

open access: yesNutrients
Lupu VV   +15 more
europepmc   +1 more source

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency

open access: yesObesity, EarlyView.
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy